I-ConFIRM Working Groups

Genetic Susceptibility

This working group currently focuses on characterising known and identifying new genes associated with kidney cancer and working with GWAS consortia to cross-validate findings.

Working Group Leader:

• Eamonn Maher, BSc, MD, FRCP, FMedSci
  University of Cambridge

Molecular Epidemiology

This working group currently focuses on pooled analyses of prospective cohort studies to investigate risk factors associated with kidney cancer.

Working Group Leader:

• Loren Lipworth, ScD
  Vanderbilt University

Tumour Characterisation and Prognostic Factors

This working group aims to test and validate prognostic markers using population studies available within the consortium.

Working Group Leaders:

• Toni Choueiri, MD
  Dana-Farber Cancer Institute and Harvard Medical School
• Mark Pomerantz, MD
  Harvard University